Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/07/1991 | CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections |
10/06/1991 | CA2039541A1 Monoclonal antibodies to avermectins |
10/05/1991 | WO1991015505A1 Purification of a pertussis outer membrane protein |
10/05/1991 | WO1991015504A1 Method to purify basic fibroblast growth factor |
10/05/1991 | WO1991015229A1 Modified heparin binding growth factors |
10/05/1991 | CA2079781A1 Method to purify basic fibroblast growth factor |
10/05/1991 | CA2079604A1 Modified heparin binding growth factors |
10/04/1991 | WO1991015574A1 Purified hcv and hcv proteins and peptides |
10/04/1991 | WO1991015512A2 Hiv envelope polypeptides |
10/04/1991 | CA2079677A1 Purified hcv and hcv proteins and peptides |
10/04/1991 | CA2078545A1 Hiv envelope polypeptides |
10/04/1991 | CA2039540A1 Modified beta adrenergic receptor |
10/03/1991 | WO1991015593A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
10/03/1991 | WO1991014786A1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap |
10/03/1991 | WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
10/03/1991 | WO1991014778A2 BACILLUS THURINGIENSIS cryIIIC GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS |
10/03/1991 | WO1991014769A1 Catalytic antibody components |
10/03/1991 | WO1991014705A1 Fused antigen polypeptide |
10/03/1991 | WO1991014695A1 Insect retinoid receptor compositions and methods |
10/03/1991 | WO1991014451A1 Bcrf1 antagonists for treating epstein-barr virus infections |
10/03/1991 | WO1991014449A1 Induction of protection against viral infection |
10/03/1991 | WO1991014438A1 Chimeric antibodies with receptor binding ligands in place of their constant region |
10/03/1991 | WO1991012273A3 Methods of producing hybrid g protein-coupled receptors |
10/03/1991 | WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof |
10/03/1991 | WO1991010735A3 Human receptor of tsh. sequence coding for such receptor |
10/03/1991 | CA2078131A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
10/03/1991 | CA2075192A1 Insect retinoid receptor compositions and methods |
10/03/1991 | CA2057040A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
10/03/1991 | CA2039259A1 Bispecific monoclonal antibodies, their production and use |
10/02/1991 | EP0449770A2 Bacterial vectors |
10/02/1991 | EP0449769A1 CD 25 binding molecules |
10/02/1991 | EP0449170A1 Cellular binding protein with affinity for human type 18 papilloma virus regulatory region |
10/02/1991 | EP0448940A2 Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone |
10/02/1991 | EP0448704A1 Osteogenic devices |
10/02/1991 | EP0448650A1 Herpes simplex virus type i expression vector |
10/02/1991 | EP0448605A1 Use of basic amino acids to solubilize immunoglobulins |
10/02/1991 | EP0409892A4 Combining mutations for stabilization of subtilisin |
10/02/1991 | CN1055010A Secretion of hirudin derivatives |
10/02/1991 | CN1055009A Production of human basic fgf-mutein |
10/01/1991 | WO1991015223A1 Respiratory burst suppression factor |
10/01/1991 | US5053327 Analyzing plant, animal, human tissue; foods |
10/01/1991 | CA2055593A1 Respiratory burst suppression factor |
10/01/1991 | CA2039359A1 Cellular binding protein having affinity for the regulatory region of the human papilloma virus type 18 |
10/01/1991 | CA1289880C Anti-human ovarian cancer immunotoxins and methods of use thereof |
10/01/1991 | CA1289870C Method of assaying myosin light chain |
09/30/1991 | WO1991014703A1 Hepatitis b vaccine |
09/30/1991 | CA2039231A1 Anti-oncostatin m monoclonal antibodies |
09/27/1991 | CA2037204A1 Method for purification of monoclonal antibodies |
09/25/1991 | EP0448513A2 Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
09/25/1991 | EP0448355A2 Antibiotic agents |
09/25/1991 | EP0448301A2 Antibiotic agents |
09/25/1991 | EP0448181A2 Interleukin-6 inhibiting compositions |
09/25/1991 | EP0448126A1 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
09/25/1991 | EP0448093A2 Secretion of hirudin derivatives |
09/25/1991 | EP0448057A1 Monoclonal antibody reactive with a novel HLA determinant on MHC class I molecules and method for activating lymphocytes |
09/25/1991 | EP0447956A1 Plasmodium sporozoite antigen |
09/25/1991 | EP0447836A2 Amyloid peptide precursor RNA |
09/25/1991 | EP0447523A1 Compositions and methods for treating or preventing infections in canine and feline animals |
09/25/1991 | EP0447493A1 New strain of bacillus thuringiensis |
09/25/1991 | EP0447489A1 Human platelet-specific antibodies |
09/25/1991 | EP0447424A1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
09/25/1991 | EP0431060A4 Method of catalyzing stereochemical reactions |
09/25/1991 | CN1054798A Vectors and compounds for expression of zymogen forms of human protein c |
09/25/1991 | CN1054794A Composite auxiliary agent for making soap |
09/24/1991 | US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems |
09/24/1991 | US5051355 Anti-human gastric cancer monoclonal antibody |
09/24/1991 | CA2038911A1 Catalytic antibody components |
09/24/1991 | CA2038533A1 Protein phosphatase inhibitor-1 gene and expression |
09/24/1991 | CA2037151A1 Plasmodium sporozoite antigen |
09/24/1991 | CA1289495C Acid stable heteropolysaccharide s-421 |
09/24/1991 | CA1289492C Process for the production of chymosin |
09/24/1991 | CA1289474C Antibodies useable as pilot agents, and compounds containing same |
09/23/1991 | CA2038706A1 Bacterial vectors |
09/23/1991 | CA2038509A1 Bu-4164e - a and b, prolyl endopeptidase inhibitors |
09/22/1991 | CA2038569A1 Process for production of peptidylglycine ó-hydroxylating monooxygenase and use thereof |
09/21/1991 | CA2038581A1 Seroreactive epitopes of human papillomavirus (hpv) 16 proteins |
09/20/1991 | CA2038532A1 Antibiotic agents |
09/20/1991 | CA2038495A1 Antibiotic agents |
09/20/1991 | CA2038397A1 Monoclonal antibody reactive with a novel hla determinant on mhc class i molecules and method for activating lymphocytes |
09/19/1991 | WO1991013993A1 Protein expression via seed specific regulatory sequences |
09/19/1991 | WO1991013985A1 Leukaemia inhibitory factor |
09/19/1991 | WO1991013983A1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3 |
09/19/1991 | WO1991013974A1 Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders |
09/19/1991 | WO1991013635A1 Labelled markers |
09/19/1991 | WO1991013630A1 ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI) |
09/19/1991 | WO1991013554A1 Protein hydrolysates |
09/19/1991 | WO1991013542A1 Transformation of plants with non-structural plant virus gene sequences |
09/19/1991 | WO1991011515A3 Leukocyte-derived growth factor |
09/19/1991 | WO1991009121A3 Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
09/19/1991 | CA2078134A1 Transformation of plants with non-structural plant virus gene sequences |
09/18/1991 | EP0447186A1 N-acylated cyclohexapeptide compounds |
09/18/1991 | EP0446931A1 Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology |
09/18/1991 | EP0446850A2 Process for purifying recombinant human beta-interferon |
09/18/1991 | EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody |
09/18/1991 | EP0446730A1 Monoclonal antibodies against complexed and non complexed complexing agent for the elimination of heavy metals from water solutions and for analysis |
09/18/1991 | EP0446619A2 Method for inhibiting bacteria using a novel lactococcal bacteriocin |
09/18/1991 | EP0446582A1 Method for producing of recombinant human cysteineless gamma-interferon free of methionine at n-terminal |
09/18/1991 | EP0446299A1 Method for site-specifically incorporating unnatural amino acids into proteins |
09/18/1991 | EP0446283A1 Synthetic interleukin-6 |